Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Martha L. Salinas Medina"'
Autor:
Tatjana Michel, Daniel Luft, Meike-Kristin Abraham, Sabrina Reinhardt, Martha L. Salinas Medina, Julia Kurz, Martin Schaller, Meltem Avci-Adali, Christian Schlensak, Karlheinz Peter, Hans Peter Wendel, Xiaowei Wang, Stefanie Krajewski
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss , Pp 459-468 (2017)
Synthetically modified mRNA is a unique bioactive agent, ideal for use in therapeutic applications, such as cancer vaccination or treatment of single-gene disorders. In order to facilitate mRNA transfections for future therapeutic applications, there
Externí odkaz:
https://doaj.org/article/bc4a700ea9284023bb3ab42a8e94a9b0
Autor:
Julia Kurz, Stefanie Krajewski, Karlheinz Peter, Martin Schaller, Martha L. Salinas Medina, Hans Peter Wendel, Sabrina Reinhardt, Meltem Avci-Adali, Christian Schlensak, Meike Kristin Abraham, Xiaowei Wang, Daniel Luft, Tatjana Michel
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss, Pp 459-468 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Synthetically modified mRNA is a unique bioactive agent, ideal for use in therapeutic applications, such as cancer vaccination or treatment of single-gene disorders. In order to facilitate mRNA transfections for future therapeutic applications, there
Autor:
Hans Peter Wendel, Andrea Nolte, Julia Kurz, Tatjana Michel, Christian Schlensak, Anna Kankura, Andreas Behring, Meltem Avci-Adali, Stefanie Krajewski, Martha L. Salinas Medina
Publikováno v:
Nucleic acid therapeutics. 25(5)
In single-gene disorders, like alpha-1-antitrypsin deficiency (AATD), a gene mutation causes missing or dysfunctional protein synthesis. This, in turn, can lead to serious complications for the patient affected. Furthermore, single-gene disorders are